Lymph Node Swelling: What Could Be Causing It

What Lymph Nodes Actually Do

Lymph nodes are small, bean-shaped organs distributed throughout your body that filter lymphatic fluid and house immune cells. They range from 1 mm to about 2 cm in healthy adults. When your immune system responds to a threat (infection, inflammation, or abnormal cell growth), the nodes nearest the affected area enlarge as lymphocytes multiply inside them.

The human body contains approximately 600 lymph nodes, grouped into superficial and deep chains [1]. You can palpate superficial nodes in the neck (cervical), armpits (axillary), and groin (inguinal). Deep nodes, such as mediastinal or mesenteric chains, are only visible on imaging.

Lymphadenopathy is defined as any lymph node abnormal in size, consistency, or number. A commonly used clinical threshold is 1 cm for most regions, though inguinal nodes up to 1.5 cm and epitrochlear nodes above 0.5 cm are considered abnormal [2]. Localized lymphadenopathy (one region) accounts for about 75% of all presentations, while generalized lymphadenopathy (two or more non-contiguous regions) makes up the remaining 25% [2]. This distinction is one of the first decision points your clinician will use.

Infections: The Most Common Cause

Reactive lymphadenopathy from infection is by far the leading explanation. In a Dutch primary-care study of 2,556 patients presenting with unexplained lymphadenopathy, only 1.1% were eventually diagnosed with a malignancy, and the vast majority had self-limited infectious or reactive causes [3].

Viral infections top the list. Upper respiratory tract infections, Epstein-Barr virus (infectious mononucleosis), cytomegalovirus (CMV), and HIV all trigger nodal enlargement. EBV-associated mononucleosis causes bilateral posterior cervical lymphadenopathy in up to 90% of affected adolescents and young adults [4]. HIV seroconversion illness produces generalized lymphadenopathy in 50% to 70% of newly infected individuals [5].

Bacterial infections represent the second largest category. Group A streptococcal pharyngitis, dental abscesses, skin and soft-tissue infections (including cat-scratch disease from Bartonella henselae), and sexually transmitted infections like syphilis and lymphogranuloma venereum all cause regional node swelling. Tuberculous lymphadenitis (scrofula) remains the most common extrapulmonary manifestation of tuberculosis worldwide, responsible for roughly 35% of extrapulmonary TB cases [6].

Other infectious agents include toxoplasmosis (often from undercooked meat or cat exposure), histoplasmosis in endemic regions, and childhood viral exanthems such as measles and rubella. The pattern matters. Bilateral, symmetric, rubbery nodes point toward viral etiology. A single, tender, warm node draining an area of cellulitis suggests bacterial origin.

Autoimmune and Inflammatory Conditions

Autoimmune diseases frequently cause lymphadenopathy that can mimic malignancy on exam. Systemic lupus erythematosus (SLE) produces lymphadenopathy in 26% to 67% of patients across published cohorts [7]. The nodes are typically diffuse, non-tender, and soft. Lupus lymphadenitis has a characteristic histological appearance, but clinicians often proceed to biopsy because the presentation overlaps with lymphoma.

Rheumatoid arthritis, Sjögren syndrome, and dermatomyositis can also enlarge regional nodes. Sarcoidosis deserves special attention. Bilateral hilar lymphadenopathy on chest X-ray is the hallmark finding, present in roughly 50% of sarcoidosis patients at diagnosis [8]. Peripheral lymphadenopathy occurs in about 15% of cases.

Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) is an underrecognized cause of cervical lymphadenopathy in young women, particularly those of East Asian descent. It is self-limiting, typically resolving within one to four months, but is frequently confused with lymphoma on initial biopsy. IgG4-related disease, Castleman disease, and Rosai-Dorfman disease round out the less common inflammatory causes that require histopathological diagnosis.

Medications That Cause Lymph Node Swelling

Drug-induced lymphadenopathy is an often-overlooked category. A thorough medication history can prevent unnecessary biopsies.

Phenytoin (Dilantin) is the most well-known offender. Phenytoin-induced lymphadenopathy develops in a small percentage of users and can present as generalized enlargement that mimics lymphoma. The reaction is a form of drug hypersensitivity and resolves after discontinuation [9]. Carbamazepine and lamotrigine carry a similar, though less frequent, risk.

Allopurinol hypersensitivity syndrome can produce lymphadenopathy alongside fever, rash, eosinophilia, and organ dysfunction. Antibiotics, particularly cephalosporins, sulfonamides, and penicillins, are occasionally implicated. Serum sickness-like reactions from these drugs cause fever, joint pain, and diffuse lymph node enlargement.

Two other categories deserve mention. Post-vaccination lymphadenopathy became widely recognized during the COVID-19 vaccination campaign. Ipsilateral axillary node swelling occurred in 11.6% of Moderna mRNA-1273 recipients after dose two in the phase III trial (N=30,420) [10]. The reaction typically resolved within days. Clinicians now recommend that mammographic screening be deferred two to six weeks after vaccination to reduce false positives.

Malignancy: When to Be Concerned

Cancer-related lymphadenopathy can be primary (lymphoma, leukemia) or metastatic (solid tumors spreading to regional nodes). Although malignancy accounts for a small fraction of all lymphadenopathy in primary care, the consequences of delayed diagnosis are significant.

Hodgkin lymphoma classically presents as painless, rubbery cervical or supraclavicular lymphadenopathy in a young adult, sometimes accompanied by "B symptoms" (unexplained fever, drenching night sweats, weight loss exceeding 10% of body weight in six months). The incidence peaks between ages 15 and 34, with a second peak after age 55 [11].

Non-Hodgkin lymphoma (NHL) is more heterogeneous. It accounts for about 4.3% of all new cancer diagnoses in the United States annually [11]. Peripheral lymphadenopathy is the most common presenting sign, but extranodal involvement (GI tract, skin, CNS) occurs in up to 40% of aggressive subtypes.

Metastatic solid tumors spread to lymph nodes via lymphatic drainage. The location of the enlarged node often points to the primary site. A hard, fixed left supraclavicular node (Virchow node) classically suggests intra-abdominal malignancy, most commonly gastric cancer. Axillary nodes raise concern for breast cancer. A supraclavicular node in any patient over 40 carries a malignancy risk as high as 90% and should always be biopsied [2].

Red flags that raise suspicion for malignancy include: node size exceeding 2 cm, hard or fixed consistency, rapid growth, absence of tenderness, supraclavicular location, persistence beyond four to six weeks, and associated constitutional symptoms.

How Lymph Node Swelling Is Diagnosed

The diagnostic approach follows an algorithm that balances thoroughness with the need to avoid unnecessary invasive procedures.

History and physical exam come first. Your clinician will assess node location, size, consistency, tenderness, mobility, duration, and associated symptoms. A focused review covers recent infections, travel, animal exposure, sexual history, medication use, constitutional symptoms, and family history of malignancy or autoimmune disease.

Laboratory studies for generalized or persistent lymphadenopathy commonly include a complete blood count with differential, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), lactate dehydrogenase (LDH), peripheral blood smear, and serologies guided by clinical suspicion (EBV, CMV, HIV, ANA, RPR). LDH elevation may suggest lymphoproliferative disease. A peripheral smear showing atypical lymphocytes points toward EBV or CMV, while blasts raise concern for acute leukemia [12].

Imaging serves as the next tier. Ultrasound is the first-line imaging modality for superficial nodes. Features such as loss of the fatty hilum, rounded morphology, cortical thickening exceeding 3 mm, and abnormal vascularity on Doppler all suggest pathology [13]. CT with contrast is used for deep lymphadenopathy and staging. PET-CT using 18F-fluorodeoxyglucose (FDG) is reserved for suspected lymphoma staging and monitoring treatment response.

Biopsy remains the definitive diagnostic step when clinical and laboratory evaluation is inconclusive or when malignancy is suspected. Excisional biopsy (removing the entire node) is preferred over fine-needle aspiration (FNA) because it preserves nodal architecture, which is required for accurate lymphoma subtyping [14]. FNA can be useful as an initial step for suspected metastatic carcinoma or infection but should not be used to rule out lymphoma.

The American Academy of Family Physicians recommends biopsy for nodes that are supraclavicular at any age, persist beyond four to six weeks without identifiable cause, are larger than 2 cm, have hard or fixed characteristics, or are accompanied by unexplained weight loss, night sweats, or hepatosplenomegaly [2].

Treatment Based on the Underlying Cause

Treatment for lymph node swelling targets the condition driving it. There is no universal therapy for "swollen lymph nodes" as a standalone symptom.

Infectious lymphadenopathy often resolves without specific treatment once the underlying infection clears. Viral causes (EBV, CMV, most upper respiratory infections) require supportive care only. Bacterial lymphadenitis may require antibiotics. Empiric coverage with a first-generation cephalosporin or amoxicillin-clavulanate targets the most common organisms (Staphylococcus aureus and Streptococcus pyogenes) in acute unilateral cervical lymphadenitis. Cat-scratch disease is typically self-limited but can be treated with azithromycin 500 mg on day one, then 250 mg daily for four days in severe cases [15]. Suppurative nodes may need incision and drainage.

Autoimmune lymphadenopathy improves with disease-directed therapy. In SLE, treatment of the underlying lupus with hydroxychloroquine, corticosteroids, or immunosuppressants typically leads to node regression. Sarcoidosis-related lymphadenopathy may not require treatment if asymptomatic but responds to systemic corticosteroids when symptomatic.

Drug-induced lymphadenopathy resolves after discontinuation of the offending agent, usually within two to four weeks.

Malignant lymphadenopathy requires oncologic management. Hodgkin lymphoma is treated with chemotherapy regimens such as ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine), achieving long-term remission in over 80% of early-stage patients [11]. Non-Hodgkin lymphoma treatment varies widely by subtype, ranging from observation for indolent follicular lymphoma to aggressive chemoimmunotherapy (R-CHOP) for diffuse large B-cell lymphoma. Metastatic nodes from solid tumors are managed according to the primary cancer's treatment protocol.

Localized vs. Generalized: What the Pattern Tells You

The distribution of enlarged nodes provides diagnostic direction. Localized lymphadenopathy (confined to one anatomical region) suggests a regional process. Cervical nodes point to head and neck infections, dental pathology, or head and neck malignancies. Axillary nodes correlate with upper extremity infections, breast pathology, or cat-scratch disease. Inguinal nodes are associated with lower extremity infections, sexually transmitted infections, and pelvic malignancies.

Generalized lymphadenopathy (two or more non-contiguous regions) narrows the differential considerably. The "CHICAGO" mnemonic helps organize causes: Cancers (lymphoma, leukemia, metastatic), Hypersensitivity (drug reactions, serum sickness), Infections (HIV, EBV, CMV, TB, syphilis, histoplasmosis), Connective tissue disease (SLE, RA, Sjögren), Atypical lymphoproliferative disorders (Castleman, Kikuchi), Granulomatous disease (sarcoidosis), and Other (amyloidosis, Gaucher disease, hyperthyroidism) [2].

HIV deserves particular emphasis. Persistent generalized lymphadenopathy (PGL), defined as enlarged nodes in two or more extrainguinal sites lasting three months or longer, is a WHO clinical stage I finding. All patients with unexplained generalized lymphadenopathy should be offered HIV testing [5].

Lymph Node Swelling in Children vs. Adults

Pediatric lymphadenopathy is overwhelmingly benign. Palpable cervical, axillary, or inguinal nodes are a normal finding in up to 44% of healthy neonates and an even higher percentage of school-age children [16]. Reactive hyperplasia from frequent childhood infections accounts for the vast majority of cases.

Despite this, certain features prompt concern in children. Supraclavicular nodes at any age are abnormal. A node that enlarges progressively over two or more weeks without infection or trauma, exceeds 2 cm to 3 cm in children, becomes fixed or matted, or is accompanied by hepatosplenomegaly or cytopenias warrants urgent evaluation for malignancy (acute lymphoblastic leukemia, neuroblastoma, Hodgkin or non-Hodgkin lymphoma) [16].

In adults over 40, the clinical calculus shifts. The probability that lymphadenopathy represents malignancy increases substantially with age. In the Dutch primary-care cohort, patients aged 40 and older had a higher biopsy yield for malignancy compared to younger patients [3]. For this reason, the threshold for biopsy is lower in older adults, particularly when the node is new, unexplained, and located in the supraclavicular or posterior cervical regions.

A practical age-based rule: in patients under 30, observation for three to four weeks is reasonable for a non-concerning node; in patients over 40 with a node exceeding 1.5 cm and no clear infectious cause, biopsy within two to three weeks is preferred [2].